Meeting Banner
Abstract #0986

Longitudinal Structural MRI & Alzheimer Disease

Dominic Holland1, Linda K. McEvoy2, Rahul S. Desikan2, Anders M. Dale, 12

1Neurosciences, UCSD, La Jolla, CA, United States; 2Radiology, UCSD

Longitudinal structural MRI enables sensitive quantification of change taking place in brain regions. When applied to Alzheimer disease, rates of structural change in specific brain regions offer potential outcome measures for clinical trials that are significantly more powerful than clinical measures, and can be combined with other baseline biomarkers for further significant enhancement of power. Rates of change can be measured with enough fidelity that annual rates of change as a function of baseline age can be calculated, revealing attenuation with increasing age in the relationship between rates of decline and disease severity, and enabling disease trajectories to be modeled.

Abstract PDF Poster PDF

Keywords

ability adequately affect affords aging allows anal annual assess assessed atrophic atrophy better boxes brain brewer calculations clinical cognitive cognitively cohort comb combined comprise dale deceleration decline detect detection disease distinguish dramatic duals elderly enable enables evidence expression faster finally fluid free function gave genetic global growing healthy ignoring improve indicators individuals initiative largely late like linearly lobe longitudinal marker mates measures medial mild mixed model modeled near older onset outcome patient patients pattern plausible population positivity possibility power powerful process prognosis pronoun proteins radiology rapid rating reduce regression relatively required resp risk sample score selecting sensitive shaw signature significantly since structural subjects subregional substantial subtle trajectories treatment trial trials unbiased whether years